{"tool_name":"prevalence","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"prevalence","home":"https://www.ambrygen.com/prevalence-tool","summary":"Mutation prevalence tables for hereditary cancer derived from multi-gene panel testing.\n\nInteractive Prevalence Tables From Multi-Gene Panel Testing.\n\nThis website describes basic, aggregated and deidentified clinical and genotype data from patients referred for hereditary cancer multigene panel testing to Ambry Genetics from March 2012 through December 2016. Data were compiled, normalized, and visualized in collaboration from researchers at the Mayo Clinic. The collaborations between Mayo Clinic And Ambry Genetics should not be seen as an endorsement of any company or product.\n\nPlease Enter Your Information to Continue.\n\nSelect which updates you would like to receive","addition_date":"2020-01-14T09:43:00Z","last_update_date":"2020-12-06T10:16:19Z"},"bioschemas":{"name":"Prevalence tool","home":"https://bio.tools/prevalence","summary":"Mutation prevalence tables for hereditary cancer derived from multi-gene panel testing.\n\nInteractive Prevalence Tables From Multi-Gene Panel Testing.\n\nThis website describes basic, aggregated and deidentified clinical and genotype data from patients referred for hereditary cancer multigene panel testing to Ambry Genetics from March 2012 through December 2016. Data were compiled, normalized, and visualized in collaboration from researchers at the Mayo Clinic. The collaborations between Mayo Clinic And Ambry Genetics should not be seen as an endorsement of any company or product.\n\nPlease Enter Your Information to Continue.\n\nSelect which updates you would like to receive","tool_type":"sc:SoftwareApplication"}}}